FIG 1
Branched pathway for tetrahydrofolate and tetrahydromonapterin synthesis in B. pseudomallei (modified from Fig. 1 in the work of Podnecky et al. [1] ). Blue text in scheme ii represents native metabolites that are expected to decrease in abundance relative to scheme i following treatment with SMX. Red text in scheme iii represents native metabolites that are expected to increase in abundance relative to scheme i due to folM mutation. The asterisk indicates an unmetabolizable product of SMX metabolism. Abbreviations: H 2 -NPt, 7,8-dihydroneopterin; H 2 -MPt, 7,8-dihydromonapterin; H 4 -MPt, tetrahydromonapterin; H 2 -HMPt-P 2 , 6-hydroxymethyl-7,8-dihydropterin pyrophosphate; PABA, para-aminobenzoic acid; H 2 -Pte, dihydropteroate; H 2 -PteGlu, dihydrofolate; H 4 -PteGlu, tetrahydrofolate; SMX, sulfamethoxazole.
